To test the hypothesis that the synthesis of intramyocellular triglycerides (imcTG) in skeletal muscle is increased in obese rats in which the content of imcTG is known to be abnormally high. ANIMALS: Sprague-Dawley male lean and high-fat-induced obese rats were studied at the age of 4, 8 and 12 months after an overnight fast, awake.
Introduction
Intramyocellular triglycerides (imcTG) content in the skeletal muscle of obese humans and animals is greater than their lean counterparts, and this increased intracellular lipid accumulation is significantly and inversely correlated with insulin sensitivity of skeletal muscle. [1] [2] [3] [4] However, the pathways that are responsible for the increase in imcTG store and the link between the increased imcTG store and insulin resistance are unknown. In fact, many of the fundamental aspects of imcTG metabolism have not been carefully studied. For example, its synthetic kinetics has not been determined under well-controlled conditions with reliable techniques. As skeletal muscle is the primary site of insulinmediated glucose uptake (hence a key site related to insulin resistance), 5 the knowledge of imcTG metabolism is important for understanding skeletal muscle insulin resistance. For imcTG content to increase, either its synthesis must increase or/and its turnover must decrease. Studies have shown that plasma free fatty acid (FFA) 6, 7 and glycerol 8 are readily incorporated into imcTG in vivo. Some studies 9 suggested that all fatty acids entering muscle fibers are rapidly esterified into imcTG pool before proceeding to any other pathways. In vitro studies also showed that increasing FFA concentration in the medium stimulates imcTG synthesis in incubated rat skeletal muscle. 10, 11 Obesity is associated with both elevated FFA and hypertriglyceridemia. Abundant such substrates can thus enter imcTG pool via its synthetic pathway causing imcTG to increase. It is thus logical to hypothesize that the synthetic limb of imcTG metabolism is likely a pathway that contributes to the increase in imcTG store.
In the present work, we report the results from a series of studies that were designed to test the hypothesis that the synthesis of imcTG in the skeletal muscle of obese rats is increased.
Materials and methods

Animals
Sprague-Dawley male rats were purchased from Harlan Sprague Dawley (Indianapolis, IN, USA). The rats of same birth dates were delivered at B100 g body weight. After 3 days, half of the rats continued to feed on regular rat chow (lean littermates), and the other half were switched to a high-fat pellet diet (55% calories from lard). Both groups were fed ad libitum, and water was freely accessible all the time. The animals were kept in a room with 12/12 light/dark cycles and stable temperature and humidity.
The main studies used 8 months old rats (nine lean and nine obese). In two subsequent studies, 4 months (five rats in each group) and 12 months (five lean, six obese) old rats were studied using the identical protocol except that plasma glycerol and FFA concentrations were matched or reversed by differential infusions of glycerol (2 and 4 mmol/kg/min) and Intralipid/heparin (2 and 1 mmol/kg/min) in lean and obese rats, respectively. Except for the 4 months old rats, the body weight of the high-fat-fed rats was Z20% overweight that of the lean controls before they were studied.
Study designs
All the animal study protocols were approved by Mayo Institutional Animal Care and Use Committee. All of the rats were studied after an overnight fast.
In the morning of the study day, the rats were transferred into a wired restraining cage. After an adaptation period of at least 30 min, a continuous, unprimed infusion of [U- 14 C]glycerol at 0.1 mCi/kg/min was initiated through a sterile i.v. infusion line into a tail vein driven by a Harvard infusion pump (Harvard Apparatus, Holliston, MA, USA). The rats were awake and most of them were relaxed throughout the infusion protocol. No anesthetics were used. At the end of the tracer infusion, pentobarbital was injected (i.v.) at a dose of 50 mg/kg to anesthetize the rat and a blood sample was taken from the left ventricle by percutaneous cardiopuncture. Then the animals were bled to death to reduce blood in muscle. Gastrocnemius, soleus and tibialis anterior were swiftly exposed and biopsied, and the muscle samples immediately immersed in liquid N 2 and shortly transferred to a À801C freezer. The blood sample was spun for 15 min at 3000 rpm and the plasma saved in the freezer.
Sample processing and analysis Muscle biopsy. The frozen muscle biopsies were thawed and thoroughly dissected under a stereomicroscope for extramyocellular adipocytes. The dissected muscle samples were then pulverized into fine powder using a steel mortar and pestle at À1001C. The muscle powder was immediately extracted for intracellular free glycerol and total lipids by Folch's method. 12 imcTG were separated from the extracted muscle total lipids by HPLC. 13 The purified imcTG were directly transmethylated by incubating at 1001C for 2 h in 2.5% H 2 SO 4 in methanol to separate the glycerol (imcTGglycerol) from the fatty acid moieties. 8 The imcTG-glycerol and the intracellular free glycerol were quantified by an enzymatic method. 14 The
14
C labels in the two glycerol fractions were determined by a liquid scintillation counter, based on which the total 14 C radioactivity and specific activity (SA) of imcTG-glycerol and the SA of muscle free glycerol were calculated.
Plasma. Plasma concentrations of FFA and free glycerol were determined using the above enzymatic methods. An aliquot of plasma was treated with an equal volume of 3 N ZnSO 4 and 3 N BaOH to precipitate the proteins. Plasma free glycerol was then separated by subjecting the diluted serum to an ion-exchange column containing 1 g of AG1 Â 8 resin (hydroxide form, 200-400 mesh) (Bio-Rad). Glycerol was eluted with 3 ml of water. The separated glycerol was used to determine 14 C-SA.
Calculations. Rate of imcTG synthesis: This is expressed as the amount of intramyocellular free glycerol incorporated into imcTG per gram of wet muscle tissue per hour. The use of glycerol as a tracer was based on our recent finding that blood glycerol is an active substrate for imcTG synthesis. 8 The use of this tracer eliminates the concerns about possible differential kinetics with fatty acid tracers, and it is extremely easy to use compared to fatty acid tracers which require the use of albumin as a carrier. Statistics. All values are mean7s.e.m. Comparisons for statistical significance were made using the two-tailed Student's t-test. We used type 2 for comparisons between animal groups, and type 1 for comparisons between different muscle groups within the same animal groups.
Results
Rat characteristics
The metabolic profiles and body weight of the 8 months old lean and obese rats are given in Table 1 . Both groups had been on their respective diets for 7 months. The obese rats Increased muscle triglyceride synthesis in obesity ZK Guo and MD Jensen were 20% heavier than their lean littermates (P ¼ 0.0001). Plasma FFA was significantly higher in obese rats by 106 mmol/l (18%) (P ¼ 0.05). However, the two groups' plasma glycerol and glucose and glycerol flux were not significantly different.
imcTG synthesis
The marked difference between lean and obese rats was the rates of incorporation of intracellular free glycerol into imcTG. At the age of 8 months, the rates for obese rats were almost four-, three and six-fold higher than that for the lean controls for gastrocnemius (P ¼ 0.001), soleus (P ¼ 0.001) and tibialis anterior (P ¼ 0.02), respectively ( Figure 1 ).
imcTG synthesis in younger rats
In order to test whether this drastic difference in imcTG synthesis is also present at younger age and when plasma glycerol and fatty acids are matched between lean and obese rats, 4 months old rats were studied using the same protocol. These rats had been on their diets for only 3 months, so their body weights were not different (chow-fed 443723 g, highfat-fed 459723 g). However, imcTG synthesis rate was more than two (148758 vs 62713, P ¼ 0.02) and five (132742 vs 2575, P ¼ 0.09) times higher for soleus and gastrocnemius, respectively, in obese rats than their lean littermates ( Figure 2 ).
imcTG synthesis in older rats
Additional rats (five lean and six obese) were raised to 12 months (on their respective diets for 11 months) and the same study protocol was repeated. Now the rats on the highfat diets were 25% heavier than their lean littermates (693727 vs 551728 g). The rate of imcTG synthesis remained higher in obese rats than their lean littermates (5078 vs 2174, P ¼ 0.01, for gastrocnemius and 44715 vs 1777, P ¼ 0.04, for soleus) ( Figure 3 ).
Intramyocellular free glycerol (the precursor for imcTG synthesis)
The concentration and SA of muscle intracellular free glycerol in the 8 months old lean and obese rats are shown in Table 2 . Glycerol concentration in gastrocnemius and soleus muscles of obese rats were significantly lower than that of lean rats (P ¼ 0.05 and 0.03, respectively). The same Increased muscle triglyceride synthesis in obesity ZK Guo and MD Jensen was seen for tibialis anterior muscle, although the difference was at a lower statistical significance level (P ¼ 0.07). The most significant difference is the specific activity of intramyocellular free glycerol: it was only about a third (gastrocnemius and tibialis anterior) and a half (soleus) that of lean rats. The differences were all highly significant (Po0.0001).
Discussion
Skeletal muscle intracellular TG are an indispensable energy source for muscle work. 15 This is especially true for human performance as this small lipid pool becomes critical for certain types of exercises (eg extended, moderate to low intensity exercises). 16, 17 It has been established now that this pool is abnormally high in obese adults and this abnormality is inversely correlated to insulin resistance, a complex metabolic syndrome currently poorly understood and seen also in a variety of other metabolic diseases (eg hypertension, diabetes, etc). Interestingly, imcTG is also increased in welltrained athletes, 18 but their insulin sensitivity is extremely high. 19 Therefore, a knowledge of not only imcTG content but also its metabolic pathways (eg synthesis, turnover) is necessary for understanding the roles played by imcTG in both human performance and diseases. Reports regarding the elevation of skeletal muscle imcTG content in obesity are extensive [1] [2] [3] [4] so that now it is often used as an index of insulin resistance. By contrast, reports on the mechanisms underlying the imcTG elevation are scarce and controversial. Kelley et al 20 suggested that decreased fatty acid oxidation may cause imcTG to accumulate with reduced insulin sensitivity in obese humans. On the other hand, Hegarty et al 21 recently reported that increased fatty acid uptake by muscle probably contributed to increased imcTG store in high-fat-fed rats with impaired insulin function; however, the effects were too small and inconclusive. Experimental data on muscle TG synthesis in obesity or insulin resistance models are still lacking, however. Although TG synthesis has been reported to be increased in other tissues such as liver in obesity models, this cannot be equated to skeletal muscle. It is incorrect to assume that an increased imcTG store must be caused by increased synthesis because imcTG hydrolysis can independently affect imcTG content. Therefore, the ultimate cause for the imcTG increase is a greater synthesis, a less active hydrolysis or a combination of both.
In the present study, we have directly measured imcTG synthesis in obesity with moderate insulin resistance (moderately reduced insulin-mediated glucose uptake, data not shown) and compared the results with their lean littermates raised in an identical environment but with different diets. The results are remarkable in that the rate of imcTG synthesis in high-fat-fed rats, both before and after they become overweight or obese, is several times greater than that in their littermate lean control. Overall, the differences in imcTG synthesis rates corresponded with the difference in their imcTG content (Table 3) . Thus, it appears likely that an accelerated imcTG synthesis may contribute to the increased imcTG store in the skeletal muscle of obesity. The acceleration in imcTG synthesis in obese rats started as early as 4 months old and only 3 months on the high-fat diet when their body weight is not greater at all, and persisted till at least mid-life (12 months old).
The accelerated muscle TG synthesis is consistent with several previous reports showing that the uptake of fatty acids by skeletal muscle is higher in similar insulin resistance models. 21, 22 This is expected, based on the present finding, because fatty acid supply must match the glycerol incorporation. Without a corresponding increase in fatty acid uptake, an increase in TG synthesis is untenable (de novo fatty acid synthesis is less in skeletal muscle). On the other hand, the underlying mechanism has not been elucidated so far. Based on the present data, it seems that obesity phenotype is the key factor for the acceleration of imcTG synthesis because the differences were independent of substrate availability. As shown in Table 4 , plasma and muscle glycerol in the 4 months old rats fed on the high-fat diet was either matched to or exceeded that seen in the chow-fed rats, whereas plasma fatty acids in the latter were made higher than in the former. By doing so, the substrate availability differences between lean and obese rats seen in the main study either disappeared or reversed (compare Table 4 with Tables 1 and 2 ). Data from 8 months old rats. Glycerol concentrations are in nmol/g ww, and SA dpm/nmol glycerol. The muscle specimens all underwent careful microdissection before the lipid analysis. TG content is determined enzymatically after saponification. n.d.: not determined.
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This strategy was meant to simulate an acute dietary change to which substrate availability is most sensitive. If diets were the factors determining the differences in imcTG synthesis (main study, Figure 1 ), this matching/reversal strategy would have corrected for it or reversed the direction of the differences. However, despite the changes in substrate availability, the same differences in imcTG synthesis between the two groups remained (Figure 2 ). This suggested that dietary factors played a minor direct role, if any, in causing the drastic differences in imcTG synthesis. Therefore, we believe that rats on the high-fat diet must have undergone adaptation so that their intrinsic metabolic setting had changed and the phenotype had been established as early as 3 months on the high-fat diet. Dietary differences, although the initial factors that triggered these changes, were not the immediate, determining factor. Although accelerated at all three ages, imcTG synthesis in obese rats at different ages differed in magnitude. Compared to the 4 months old rats, the 8 months old rats had much higher levels of imcTG synthesis in gastrocnemius and soleus (Figures 1 and 2) . However, by the age of 12 months, this activity seemed to have slowed down substantially ( Figure 3) . We interpret the differential imcTG synthesis rates at different ages to be consistent with aging physiology as seen in humans, where aging is associated with reduced physical activity and resting metabolic rate. 23 A 4 months old is equivalent to a teen in humans, a period characterized by fresh and fast growth in muscle activities. At the age of 8 months, it is equivalent to 20 s in humans and is the physically most active period. The measured imcTG synthesis in these two groups was highly active, especially at 8 months. The 12 months old rats are in their middle age characterized by somewhat slowed physical activities, and so are their needs for imcTG as an alternative energy source. In this regard, the two groups appeared comparable because the data for lean rats displayed similar patterns.
It should be noted that the macronutrient compositions of the diets used for the two groups were drastically different: the control diet contains 49% (w/w) of carbohydrates (mainly starch) and the high-fat diet contains only 24% (w/w) carbohydrates as starch. Therefore, much larger amount of glucose had been consumed by the control rats. Had this resulted in a large underestimation of imcTG synthesis for the control rats because the glycerol 3-phosphate derived from glucose is directly incorporated into imcTG? Based on our previous finding that glucose is a minor carbon source for imcTG-glycerol in fasted rats, 8 the answer seems to be negative. For the soleus, glucose contributes only B10% of imcTG-glycerol carbons, and the corresponding value for gastrocnemius is 35%, with the remainder from glycerol. Thus, the majority of the imcTGglycerol carbons were derived from glycerol, not from glucose, in these fasted rats.
It is interesting to notice from the present studies that the specific activity of intramyocellular free glycerol in all three muscles is markedly lower in obese rats even in the face of its low concentration ( Table 2) . The difference remains after correction for differences in plasma tracer concentration (data not shown). In principle, a lower concentration should accompany a higher SA. Our data showed the exact opposite. We reasoned that the result is consistent with an accelerated intramyocellular glycerol recycling via repeated glycerol incorporation into and release from imcTG (TG-glycerol cycle). An accelerated TG-glycerol recycling will dilute the free glycerol pool because the glycerol released from imcTG is unlabeled. On the other hand, the smaller pool size of free glycerol is consistent with the enlarged imcTG pool that serves as a sink of glycerol (Table 3) . And this serves to reinforce the supposition that an active TG-glycerol cycling exists in the skeletal muscle of obese rats.
Owing to technical difficulties, many data from previous skeletal muscle lipid metabolism studies are questionable due to contamination of muscle specimens by extracellular adipocytes. 24 Until recently, this has been an issue of controversy for a long time as to whether it is possible to obtain pure muscle fibers for metabolic studies. Now we have shown that it is feasible and relatively easy to accomplish this by subjecting muscle biopsy to careful microdissection. 24, 25 We consider the clarification of this key issue and the establishment of the technique for muscle sample decontamination as an important advance in the investigation of skeletal muscle lipid and its metabolism. 24 Now microdissection of all muscle samples becomes mandatory before any lipid analysis. The present studies were conducted by strictly following this procedure. Therefore, there are no concerns on the reliability of the present results. In summary, we have determined imcTG synthesis in a rodent obesity model at different developmental stages using reliable techniques. The results confirmed our original hypothesis that the synthesis of imcTG in the skeletal muscle of obesity is accelerated and this appeared to be caused by phenotypic differences. Further studies of imcTG turnover/recycling may prove fruitful in advancing our understanding of imcTG accumulation and its relation with insulin resistance. Data are from 4 months old rats (3 months on the high-fat diet) in which glycerol and Intralipid were infused at different rates (see Methods for the details) aimed at matching or reversing plasma and muscle substrate concentrations between chow-fed and high-fat-fed rats.
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